APA (7th ed.) Citation

Cortellini, A., Giusti, R., Filetti, M., Citarella, F., Adamo, V., Santini, D., . . . Genova, C. (2022). High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. Journal of Hematology & Oncology, 15(1), 1. https://doi.org/10.1186/s13045-022-01226-2

Chicago Style (17th ed.) Citation

Cortellini, Alessio, et al. "High Familial Burden of Cancer Correlates with Improved Outcome from Immunotherapy in Patients with NSCLC Independent of Somatic DNA Damage Response Gene Status." Journal of Hematology & Oncology 15, no. 1 (2022): 1. https://doi.org/10.1186/s13045-022-01226-2.

MLA (9th ed.) Citation

Cortellini, Alessio, et al. "High Familial Burden of Cancer Correlates with Improved Outcome from Immunotherapy in Patients with NSCLC Independent of Somatic DNA Damage Response Gene Status." Journal of Hematology & Oncology, vol. 15, no. 1, 2022, p. 1, https://doi.org/10.1186/s13045-022-01226-2.